Medicare Enrolled

Dr. David Young, DO

Pulmonary Disease · Wyomissing, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2608 KEISER BLVD, Wyomissing, PA 19610
6106855864
In practice since 2010 (16 years)
NPI: 1285954321 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Young from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Young? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Young

Dr. David Young is a pulmonary disease specialist in Wyomissing, PA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Young performed 2,072 Medicare services across 1,384 unique beneficiaries.

Between the years covered by Open Payments, Dr. Young received a total of $7,565 from 41 pharmaceutical and/or device companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Young is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 8% volume in PA $7,565 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,072
Medicare services
Top 8% in PA for pulmonary disease
1,384
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~130 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
539 $92 $151
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
435 $2 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
239 $65 $134
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
171 $132 $294
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
154 $94 $191
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
103 $169 $412
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
100 $32 $64
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
100 $41 $86
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
79 $27 $90
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
49 $10 $21
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
29 $9 $21
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
26 $20 $43
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $120 $247
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $128 $266
Bronchial irrigation and suction for cell collection
This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing.
11 $29 $381
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,565
Total received (2018-2024)
Avg $1,081/year across 7 years
Top 23% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
166
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,978 (52.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,587 (47.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,044
2023
$980
2022
$4,629
2021
$197
2020
$116
2019
$304
2018
$295

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$227
GENZYME CORPORATION
$206
Regeneron Healthcare Solutions, Inc.
$128
Mylan Specialty L.P.
$107
GlaxoSmithKline, LLC.
$87
Avadel CNS Pharmaceuticals, LLC
$37
Merck Sharp & Dohme LLC
$34
HARMONY BIOSCIENCES LLC
$32
Insmed, Inc.
$32
Axsome Therapeutics, Inc.
$32
Harmony Biosciences Llc
$28
United Therapeutics Corporation
$23
ANI Pharmaceuticals, Inc.
$21
Inari Medical, Inc.
$18
Novartis Pharmaceuticals Corporation
$17
Vifor Pharma, Inc.
$15
Top 3 companies account for 53.8% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$3,978
AstraZeneca Pharmaceuticals LP
$574
GlaxoSmithKline, LLC.
$557
GENZYME CORPORATION
$326
Regeneron Healthcare Solutions, Inc.
$274
Mylan Specialty L.P.
$235
Inari Medical, Inc.
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
Pulmonx Corporation
$130
Insmed, Inc.
$105
BOSTON SCIENTIFIC CORPORATION
$101
Boston Scientific Corporation
$94
Axsome Therapeutics, Inc.
$79
United Therapeutics Corporation
$61
Merck Sharp & Dohme LLC
$52
Mallinckrodt LLC
$44
Shire North American Group Inc
$42
Ambu Inc.
$40
Avadel CNS Pharmaceuticals, LLC
$37
Actelion Pharmaceuticals US, Inc.
$36
Mallinckrodt Hospital Products Inc.
$34
HARMONY BIOSCIENCES LLC
$32
Mallinckrodt Enterprises LLC
$32
Circassia Pharmaceuticals Inc
$31
Harmony Biosciences Llc
$28
Merck Sharp & Dohme Corporation
$27
Harmony Biosciences LLC
$24
Amgen Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
ANI Pharmaceuticals, Inc.
$21
Genentech USA, Inc.
$20
Exeltis, USA Inc.
$19
Vanda Pharmaceuticals Inc.
$19
Janssen Pharmaceuticals, Inc
$19
Inspire Medical Systems, Inc.
$18
E.R. Squibb & Sons, L.L.C.
$17
Novartis Pharmaceuticals Corporation
$17
Takeda Pharmaceuticals U.S.A., Inc.
$16
Vifor Pharma, Inc.
$15
Philips Electronics North America Corporation
$14
PFIZER INC.
$13
Top 3 companies account for 67.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · Arikayce · BREO · BREZTRI · CHANTIX · CHARTIS CATHETER · COREDX · CT THROMBECTOMY SYSTEM KIT · CoreDx · DUPIXENT · Da Vinci Surgical System · ELIQUIS · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Hetlioz · INSPIRE · ION · KEYTRUDA · LUMRYZ · NUCALA · OFEV · OPSUMIT · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · S · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Tavneos · Veltassa · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.

Looking for a pulmonary disease specialist in Wyomissing?
Compare pulmonary diseases in the Wyomissing area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
13
Per 100K population
3.0
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Young is a clinical cardiology specialist, with above-average Medicare volume (top 8% in PA), with speaking/promotional industry engagement, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Young experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Young performed 539 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Young receive payments from pharmaceutical companies?
Yes. Dr. Young received a total of $7,565 from 41 companies across 166 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Young's costs compare to other pulmonary diseases in Wyomissing?
Dr. Young's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Young) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →